Peptide Mots-C CAS 1627580-64-6 Acetate Peptide Powder 10mg/vial Betty
131 Inquiries
1627580-64-6
ep
99%
HongKong
10vials
2026-11-08
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceMOTS-C Synthetic is a single, non-glycosylated polypeptide chain containing 16 amino acids, having a molecular mass of 2174.59 Dalton and a Molecular formula of C10H152N280O22 S2.Basic Info
-
Product Name:
MOTS-c
Other Name:MOTS-c;L-Arginine, L-methionyl-L-arginyl-L-tryptophyl-L-glutaminyl-L-α-glutamyl-L-methionylglycyl-L-tyrosyl-L-isoleucyl-L-phenylalanyl-L-tyrosyl-L-prolyl-L-arginyl-L-lysyl-L-leucyl-;MOTS-C acetate;Cosmetic Peptide Mots-C;MOTS-c POWDER;MOTS-c peptide;MOTS-c 5mg/10mg;H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH
CAS No.:1627580-64-6
Molecular Formula:C101H152N28O22S2
InChIKeys:WYTHCOXVWRKRAH-JIJBDQHHNA-N
Molecular Weight:2174.62
Exact Mass:2174.1110958
EC Number:200-001-8
Color/Form:Solid lyophilized powder
Categories:
Characteristics-
Density:
1.44±0.1 g/cm3(Predicted)
Critical Temperature & Pressure:Store at -20°C
Research-
Class:
Mitochondrial-derived peptide (MDP), 16-amino-acid peptide
Status:Research compound — Not FDA approved
Mechanism:MOTS-c (mitochondrial ORF of the twelve S rRNA-c) is a 16-amino-acid peptide encoded by the mitochondrial genome (not nuclear DNA). It is a mitochondrial-derived peptide that regulates metabolic homeostasis by activating the AMPK/PGC-1\u03b1 pathway, improving insulin sensitivity, and enhancing exercise capacity. MOTS-c crosses the blood-brain barrier and has been shown to reduce body weight and improve glucose tolerance in preclinical models.
Activity note:MOTS-c does not act via a traditional receptor. It functions as a metabolic regulator, activating AMPK. Functional effects are observed at micromolar concentrations in cell-based assays.
Source:Lee C, et al. Cell Metab. 2015;21(3):443-454. MCE: MOTS-c (CAS 1627580-64-6).DOI
References-
PubChem:Disclaimer:
MOTS-c is NOT FDA-approved or EMA-approved. It is a research compound only. All data are from preclinical (cell/animal) studies; no human clinical trials have been completed. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Location:
1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province
-
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA
-
-
Inquiry History131 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Mots-C CAS 1627580-64-6
5 G Apr 26, 2026
United States
Bodygrowth Peptides CAS 1627580-64-6 MOTS-c (Human) Acetate peptides powder
1 G Feb 23, 2026
United States
MOTS-c (Human) Acetate peptides powder
1 G Mar 12, 2026 
Brazil
MOTS-c 10mg Peptide Raw Material High Purity
10 PCS Feb 17, 2026
United States
Mots-C
1 KG Sep 12, 2025 
United Kingdom
mots-c
15 MG Aug 3, 2026
United States
Mots c
10 MG Jul 23, 2026
United States
MOTS-c
20 MG Jul 21, 2026 
Azerbaijan
Mots-c
5 G Jun 25, 2026
United States
MOTS-c
500 MT Jun 22, 2026
United States
Mots-c
1 MT Jun 16, 2026 
Australia
MOTS-c 50mg
30 PCS May 25, 2026
United States
Mots C
4000 MG May 20, 2026 
China
Mots-C
10000 MT May 19, 2026
Brazil
most-C
1 KG May 12, 2026 
Canada
Mots-c
1 KG Apr 23, 2026 
Greece
MOTS-C
10 G Apr 14, 2026 
Pakistan
MOTS-C
10 PCS Apr 6, 2026
United States
Mots-C
10 MT Apr 4, 2026
United States
Mots-c
100 MG Mar 29, 2026 Post an enquiry for this product
